I agree that this site is using cookies. You can find further informations here.
X
Gyllensten, H.
328  results:
Search for persons X
?
1

PCR265 A Core Outcome Set for the Evaluation of New Healthc..:

Harvey, B. ; Barenfeld, E. ; Öhlén, J....
Value in Health.  26 (2023)  12 - p. S501 , 2023
Link: https://doi.org/10.1016/..
 
?
2

EE611 Economic Evaluation of Person-Centred Care Using a Di..:

Harvey, B. ; Barenfeld, E. ; Fors, A..
Value in Health.  26 (2023)  12 - p. S170-S171 , 2023
Link: https://doi.org/10.1016/..
 
?
3

EE377 Healthcare Utilization and Costs Among Acutely Hospit..:

Robinson, EG ; Gyllensten, H ; Granas, AG...
Value in Health.  25 (2022)  12 - p. S129 , 2022
Link: https://doi.org/10.1016/..
 
?
4

PND54 COST-OF-ILLNESS TRAJECTORIES AMONG NEWLY DIAGNOSED MS..:

Karampampa, K. ; Gyllensten, H. ; Friberg, E....
Value in Health.  22 (2019)  - p. S746 , 2019
Link: https://doi.org/10.1016/..
 
?
5

PNS198 PHARMACY COST OF PREVENTING ADVERSE DRUG EVENTS BY P..:

Robinson, E.G. ; Smedberg, J. ; Gyllensten, H..
Value in Health.  22 (2019)  - p. S794 , 2019
Link: https://doi.org/10.1016/..
 
?
6

PND35 - HEALTHCARE, SICKNESS ABSENCE, AND DISABILITY PENSIO..:

Karampampa, K ; Gyllensten, H ; Yang, F...
Value in Health.  21 (2018)  - p. S335 , 2018
Link: https://doi.org/10.1016/..
 
?
7

Costs and disability among multiple sclerosis patients: A S..:

Gyllensten, H ; Friberg, E ; Kavaliunas, A...
European Journal of Public Health.  27 (2017)  suppl_3 - p. , 2017
Link: https://doi.org/10.1093/..
 
?
8

Direct and indirect costs of adverse drug events:

Gyllensten, H ; Hakkarianen, KM ; Rehnberg, C...
European Journal of Public Health.  27 (2017)  suppl_3 - p. , 2017
Link: https://doi.org/10.1093/..
 
?
9

Economic analysis of a person-centered care intervention in..:

Gyllensten, H ; Koinberg, I ; Carlström, E..
European Journal of Public Health.  27 (2017)  suppl_3 - p. , 2017
Link: https://doi.org/10.1093/..
 
?
10

Costs of Illness Progression for Different Multiple Scleros..:

Gyllensten, H ; Kavaliunas, A ; Hillert, J...
Value in Health.  20 (2017)  9 - p. A407 , 2017
Link: https://doi.org/10.1016/..
 
?
11

P615Hospitalization, costs and diagnosis in patients with t..:

Wallstrom, S. ; Ekman, I. ; Ulin, K..
European Heart Journal.  38 (2017)  suppl_1 - p. , 2017
Link: https://doi.org/10.1093/..
 
?
12

Comparing indirect costs of multiple sclerosis in three dif..:

Gyllensten, H ; Wiberg, M ; Alexanderson, K...
European Journal of Public Health.  26 (2016)  suppl_1 - p. , 2016
Link: https://doi.org/10.1093/..
 
?
13

Cost of Illness of Multiple Sclerosis - A systematic review:

Ernstsson, O ; Gyllensten, H ; Alexanderson, K...
European Journal of Public Health.  25 (2015)  suppl_3 - p. , 2015
Link: https://doi.org/10.1093/..
 
?
14

Economic Impact Of Drug-Related Morbidity In Sweden:

Gyllensten, H
Value in Health.  18 (2015)  7 - p. A532 , 2015
Link: https://doi.org/10.1016/..
 
?
15

Costs of Illness of Multiple Sclerosis In Sweden – A Popula..:

Gyllensten, H ; Wiberg, M ; Tinghög, P...
Value in Health.  18 (2015)  7 - p. A753-A754 , 2015
Link: https://doi.org/10.1016/..
 
1-15